135 related articles for article (PubMed ID: 1581459)
21. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus].
Yang JH; Shen Q; Zhao DB; Cai Q; Han XH
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):318-23. PubMed ID: 15854508
[TBL] [Abstract][Full Text] [Related]
22. Costimulatory molecule CD154 in systemic lupus erythematosus and rheumatoid arthritis. Therapeutic perspectives.
Dejica DI; Manea EM
Roum Arch Microbiol Immunol; 2006; 65(1-2):66-74. PubMed ID: 17877113
[TBL] [Abstract][Full Text] [Related]
23. Common variable immunodeficiency in systemic lupus erythematosus.
Fernández-Castro M; Mellor-Pita S; Citores MJ; Muñoz P; Tutor-Ureta P; Silva L; Vargas JA; Yebra-Bango M; Andreu JL
Semin Arthritis Rheum; 2007 Feb; 36(4):238-45. PubMed ID: 17276173
[TBL] [Abstract][Full Text] [Related]
24. Defects in Notch1 upregulation upon activation of T Cells from patients with systemic lupus erythematosus are related to lupus disease activity.
Sodsai P; Hirankarn N; Avihingsanon Y; Palaga T
Lupus; 2008 Jul; 17(7):645-53. PubMed ID: 18625637
[TBL] [Abstract][Full Text] [Related]
25. [Clinical significance of lymphocyte populations].
Flad HD
Med Klin; 1979 Aug; 74(34):1199-206. PubMed ID: 388169
[No Abstract] [Full Text] [Related]
26. Studies of immune abnormalities in systemic lupus erythematosus.
Steinberg AD; Smith HR; Laskin CA; Steinberg BJ; Smolen JS
Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):101-10. PubMed ID: 6213146
[TBL] [Abstract][Full Text] [Related]
27. Sex hormones and peripheral white blood cell subsets in systemic lupus erythematosus patients.
Rastin M; Hatef MR; Tabasi N; Sheikh A; Morad Abbasi J; Mahmoudi M
Iran J Immunol; 2007 Jun; 4(2):110-5. PubMed ID: 17652851
[TBL] [Abstract][Full Text] [Related]
28. Systemic lupus erythematosus: all roads lead to type I interferons.
Pascual V; Farkas L; Banchereau J
Curr Opin Immunol; 2006 Dec; 18(6):676-82. PubMed ID: 17011763
[TBL] [Abstract][Full Text] [Related]
29. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
Kammer GM; Birch RE; Polmar SH
J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
[TBL] [Abstract][Full Text] [Related]
30. Cellular immunity and its regulation in SLE.
Alarcón-Segovia D
Clin Rheum Dis; 1982 Apr; 8(1):63-75. PubMed ID: 6214366
[No Abstract] [Full Text] [Related]
31. [Role of T lymphocytes in systemic lupus erythematosus].
Zubler RH; Miescher PA
Ann Med Interne (Paris); 1990; 141(3):208-12. PubMed ID: 2195945
[TBL] [Abstract][Full Text] [Related]
32. Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients.
Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR
Clin Exp Immunol; 2005 Jul; 141(1):165-73. PubMed ID: 15958083
[TBL] [Abstract][Full Text] [Related]
33. [Tumor-induced immunosuppression in breast cancer patients].
Kharkevich DD; Polevaia EB; Kadagidze ZG
Eksp Onkol; 1990; 12(5):53-6. PubMed ID: 2226260
[TBL] [Abstract][Full Text] [Related]
34. Cellular immunological dysfunction in systemic lupus erythematosus.
Chee YC
Singapore Med J; 1982 Feb; 23(1):12-8. PubMed ID: 6214005
[No Abstract] [Full Text] [Related]
35. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus.
Bruns A; Bläss S; Hausdorf G; Burmester GR; Hiepe F
Arthritis Rheum; 2000 Oct; 43(10):2307-15. PubMed ID: 11037891
[TBL] [Abstract][Full Text] [Related]
36. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
37. Limited effect of eicosapentaenoic acid on T-lymphocyte and natural killer cell numbers and functions in healthy young males.
Miles EA; Banerjee T; Wells SJ; Calder PC
Nutrition; 2006 May; 22(5):512-9. PubMed ID: 16600816
[TBL] [Abstract][Full Text] [Related]
38. Soluble interleukin 2 receptor levels in serum and its relationship to T cell abnormality and clinical manifestations of the disease in patients with systemic lupus erythematosus.
Raziuddin S; al-Janadi MA; al-Wabel AA
J Rheumatol; 1991 Jun; 18(6):831-6. PubMed ID: 1680190
[TBL] [Abstract][Full Text] [Related]
39. [Comparative characteristics of immunological tests in differentiation of systemic and cutaneous forms of lupus erythematosus].
Romanova NV; Shilkina NP
Ter Arkh; 2009; 81(4):40-3. PubMed ID: 19514420
[TBL] [Abstract][Full Text] [Related]
40. [B-cell anomalies in systemic lupus erythematosus].
Tron F; Jacquot S; Gilbert D
Ann Med Interne (Paris); 2002 Dec; 153(8):503-12. PubMed ID: 12610424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
